September 4, 2025
BVI Introduces Virtuoso at EURetina
The dual-function phaco-vitrectomy device has not yet received regulatory clearance.
2025 Euretina Congress
Related Articles
September 4, 2025
Migaldendranib Demonstrates Efficacy in DME and nAMD
Phase 2 results presented at Euretina showed reduced injection frequency as well as improvements in retinal structure and visual function.
September 4, 2025
Study Connects Iron Regulation and Vision Loss
Data presented at the EURetina congress in Paris highlight transferrin’s potential role in dry AMD progression.
September 4, 2025
Head-to-Head Trial Compares Iluvien and Anti-VEGF
Patients with diabetic macular edema who received the Iluvien implant needed less than half as many injections as those treated with aflibercept alone.
September 4, 2025
Initial DIAMOND Results Support OCS-01 Efficacy
Data on patients with DME, reported at Euretina, show BCVA gains and improvement in retinal thickness at 12 weeks.
September 4, 2025
Prithvi Ramtohul Receives Tadayoni Award
The award, established in memory of the late Ramin Tadayoni, MD, PhD, and presented at Euretina, supports talented retina researchers with a significant grant.